Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: a population-based prospective study.
about
Epidermal growth factor receptor in non-small cell lung cancerThe frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study.ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation.Epidermal growth factor receptor gene mutation status and its association with clinical characteristics and tumor markers in non-small-cell lung cancer patients in Northwest ChinaPredictive value of K-ras and PIK3CA in non-small cell lung cancer patients treated with EGFR-TKIs: a systemic review and meta-analysis.EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII).microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers.Molecular epidemiology of female lung cancerHistological subtype and smoking status, but not gender, are associated with epidermal growth factor receptor mutations in non-small-cell lung cancer.EGFR G796D mutation mediates resistance to osimertinib.k-RAS mutations in non-small cell lung cancer patients treated with TKIs among smokers and non-smokers: a meta-analysis.Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR.Discrepancies between ALK protein disruption and occurrence of gene rearrangement in Polish NSCLC patients
P2860
Q28088636-696A17F1-A2F9-480A-8DEF-A4BC08696F95Q30539397-8A9F3396-AA5E-46C4-B413-1FBF5D2127ACQ35087767-CCD00522-10D8-45E4-9324-644DAE6F7BA6Q35802647-A5A8B63D-BBF4-4E29-8BD5-A85156DF3931Q35824117-B151ED25-3DC4-4FD8-86DB-8069ACE7FD84Q36250691-E5083AF3-C104-4BD5-B6CF-0434FF54E5F3Q36354817-FEB1A39A-891B-4D0D-8275-F7769039F0AFQ37132684-C2CAC93F-838C-401B-8C19-2F0B95B26251Q37567792-B0BB2634-F6D0-4F0C-B731-7BEB9F87AE58Q41472663-0DB1F2E5-DEFB-4076-9A9C-81B849019AA4Q42009257-ECED31C3-2A69-491D-B217-0B4B32FC2715Q48203761-A9EE81FF-F93D-47EC-A383-4BFE499E517CQ58804485-23299C62-1E0C-42A1-8359-7A0A335DE696
P2860
Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: a population-based prospective study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Epidermal growth factor recept ...... ation-based prospective study.
@en
Epidermal growth factor recept ...... ation-based prospective study.
@nl
type
label
Epidermal growth factor recept ...... ation-based prospective study.
@en
Epidermal growth factor recept ...... ation-based prospective study.
@nl
prefLabel
Epidermal growth factor recept ...... ation-based prospective study.
@en
Epidermal growth factor recept ...... ation-based prospective study.
@nl
P2093
P50
P356
P1433
P1476
Epidermal growth factor recept ...... lation-based prospective study
@en
P2093
Adele Servadio
Alfredo Mussi
Camilla E Comin
Carmelo Tibaldi
Cristina Maddau
Editta Baldini
Marco Lucchi
Silvia Gisfredi
Silvia Ursino
P304
P356
10.3892/OR_00000488
P577
2009-10-01T00:00:00Z